ATE380866T1 - Modulatoren des tnf-rezeptor-assoziierten faktors,deren herstellung und verwendungen - Google Patents
Modulatoren des tnf-rezeptor-assoziierten faktors,deren herstellung und verwendungenInfo
- Publication number
- ATE380866T1 ATE380866T1 AT97914534T AT97914534T ATE380866T1 AT E380866 T1 ATE380866 T1 AT E380866T1 AT 97914534 T AT97914534 T AT 97914534T AT 97914534 T AT97914534 T AT 97914534T AT E380866 T1 ATE380866 T1 AT E380866T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- associated factor
- tnf receptor
- proteins
- factor modulators
- Prior art date
Links
- 102000008889 TNF receptor-associated factor TRAF Human genes 0.000 title 1
- 108050000808 TNF receptor-associated factor TRAF Proteins 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000003298 tumor necrosis factor receptor Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11780096A IL117800A0 (en) | 1996-04-02 | 1996-04-02 | Modulators of TNF receptor associated factor (TRAF) their preparation and use |
| IL11913396A IL119133A0 (en) | 1996-08-26 | 1996-08-26 | Modulators of TNF receptor associated factor (TRAF) their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380866T1 true ATE380866T1 (de) | 2007-12-15 |
Family
ID=26323248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97914534T ATE380866T1 (de) | 1996-04-02 | 1997-04-01 | Modulatoren des tnf-rezeptor-assoziierten faktors,deren herstellung und verwendungen |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7485456B1 (de) |
| EP (1) | EP0894130B1 (de) |
| JP (1) | JP4180114B2 (de) |
| CN (1) | CN1197966C (de) |
| AT (1) | ATE380866T1 (de) |
| AU (1) | AU732793B2 (de) |
| BG (1) | BG64755B1 (de) |
| BR (1) | BR9708518A (de) |
| CA (1) | CA2250085C (de) |
| CZ (3) | CZ299682B6 (de) |
| DE (1) | DE69738370T2 (de) |
| DK (1) | DK0894130T3 (de) |
| EA (1) | EA004309B1 (de) |
| EE (1) | EE04783B1 (de) |
| ES (1) | ES2294796T3 (de) |
| HU (1) | HU226328B1 (de) |
| NO (1) | NO327054B1 (de) |
| NZ (1) | NZ331902A (de) |
| PT (1) | PT894130E (de) |
| SK (3) | SK287890B6 (de) |
| UA (1) | UA71889C2 (de) |
| WO (1) | WO1997037016A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA71889C2 (uk) * | 1996-04-02 | 2005-01-17 | Йєда Рісерч Енд Дівелопмент Ко. Лтд. | Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування |
| US5843721A (en) * | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
| WO1999024469A1 (en) * | 1997-11-07 | 1999-05-20 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| US6265538B1 (en) * | 1998-02-27 | 2001-07-24 | The Regents Of The University Of California | Inhibitor of the inflammatory response induced by the TNFA and IL-1 |
| ATE309352T1 (de) | 1998-05-06 | 2005-11-15 | Vlaams Interuniv Inst Biotech | Inhibitoren der nf-kb aktivierung |
| IL141355A0 (en) * | 1998-08-18 | 2002-03-10 | Basf Biores Corp | Tpl-2/cot kinase and methods of use |
| IL131719A0 (en) | 1999-09-02 | 2001-03-19 | Yeda Res & Dev | Iren protein its preparation and use |
| GB9930616D0 (en) * | 1999-12-24 | 2000-02-16 | Mathilda & Terence Kennedy Ins | Activation and inhibition of the immune system |
| KR20020069140A (ko) * | 2001-02-21 | 2002-08-29 | 주식회사 코메드 | 종양 괴사 인자 수용체 관련 인자 6 억제 단백질 |
| WO2003000280A2 (en) | 2001-06-22 | 2003-01-03 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Abin-mediated hepatitis protection |
| SI1499729T1 (sl) * | 2002-04-18 | 2011-11-30 | Yeda Res & Dev | Derivati encima ki inducira nf-kappab njihova priprava in uporaba |
| JP4943848B2 (ja) * | 2003-10-07 | 2012-05-30 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | Nikに対する抗体、その調製および使用 |
| IL158287A0 (en) * | 2003-10-07 | 2004-05-12 | Yeda Res & Dev | Antibodies to nik, their preparation and use |
| WO2005051423A2 (en) * | 2003-11-30 | 2005-06-09 | Yeda Research And Development Co. Ltd | Methods and agents for immune modulation and methods for identifying immune modulators |
| IL173104A0 (en) * | 2006-01-12 | 2006-06-11 | Yeda Res & Dev | Siva and ubiquintination |
| KR20110036638A (ko) | 2008-07-25 | 2011-04-07 | 리차드 더블유. 와그너 | 단백질 스크리닝 방법 |
| GB201012420D0 (en) | 2010-07-23 | 2010-09-08 | Univ Erasmus Medical Ct | Foetal heamoglobin inhibitor |
| JP5964304B2 (ja) | 2010-08-25 | 2016-08-03 | エータイアー ファーマ, インコーポレイテッド | チロシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| CN105177032B (zh) * | 2010-09-01 | 2019-05-10 | 山东新时代药业有限公司 | 新型人肿瘤坏死因子受体-Fc融合基因及其产物蛋白 |
| AR085908A1 (es) | 2011-03-16 | 2013-11-06 | Hoffmann La Roche | DERIVADOS DE 3-BUTIN-2-OL Y DE CARBONITRILO CON ACTIVIDAD INHIBIDORA DE LA QUINASA INDUCTORA DE NF-kB (NIK) |
| RU2657440C2 (ru) | 2011-06-30 | 2018-06-13 | Джензим Корпорейшн | Ингибиторы т-клеточной активации |
| US9549981B2 (en) | 2011-07-19 | 2017-01-24 | Philogen S.P.A. | Sequential antibody therapy |
| UY34317A (es) | 2011-09-12 | 2013-02-28 | Genzyme Corp | Anticuerpo antireceptor de célula T (alfa)/ß |
| WO2015109391A1 (en) | 2014-01-24 | 2015-07-30 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Smc combination therapy for the treatment of cancer |
| CN105986001B (zh) * | 2015-02-12 | 2019-12-03 | 上海交通大学 | 一种基于膜结合蛋白和荧光互补的高通量猎物拮抗剂筛选方法 |
| CN108026172B (zh) | 2015-06-26 | 2022-04-29 | 赛诺菲生物技术公司 | 单克隆抗il-1racp抗体 |
| EP3401332A1 (de) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anti-il-1r3 antikörper zur verwendung bei entzündungskrankheiten |
| JP7575401B2 (ja) | 2019-04-03 | 2024-10-29 | ジェンザイム・コーポレーション | 断片化が低減した抗アルファベータtcr結合ポリペプチド |
| US12054552B2 (en) | 2022-09-21 | 2024-08-06 | Sanofi Biotechnology | Humanized anti-IL-1R3 antibody and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5641876A (en) * | 1990-01-05 | 1997-06-24 | Cornell Research Foundation, Inc. | Rice actin gene and promoter |
| CA2228039A1 (en) * | 1995-08-02 | 1997-02-13 | Teresa J. Ingram | Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome |
| AU6692996A (en) | 1995-08-08 | 1997-03-05 | Tularik Inc. | Inhibitors of apoptosis |
| US5804412A (en) * | 1996-04-01 | 1998-09-08 | The Regents Of The University Of California | Nucleic acids encoding sorting nexins and methods of using same |
| UA71889C2 (uk) * | 1996-04-02 | 2005-01-17 | Йєда Рісерч Енд Дівелопмент Ко. Лтд. | Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування |
| JP2000509713A (ja) | 1996-05-08 | 2000-08-02 | ヘンケル コーポレーション | アルキルポリグリコシドエーテルカルボン酸 |
| US5843721A (en) * | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
-
1997
- 1997-01-04 UA UA98105743A patent/UA71889C2/uk unknown
- 1997-04-01 JP JP53509997A patent/JP4180114B2/ja not_active Expired - Lifetime
- 1997-04-01 CA CA002250085A patent/CA2250085C/en not_active Expired - Lifetime
- 1997-04-01 PT PT97914534T patent/PT894130E/pt unknown
- 1997-04-01 EE EE9800322A patent/EE04783B1/xx unknown
- 1997-04-01 BR BR9708518A patent/BR9708518A/pt not_active Application Discontinuation
- 1997-04-01 US US09/155,676 patent/US7485456B1/en not_active Expired - Fee Related
- 1997-04-01 NZ NZ331902A patent/NZ331902A/en not_active IP Right Cessation
- 1997-04-01 DK DK97914534T patent/DK0894130T3/da active
- 1997-04-01 SK SK50017-2007A patent/SK287890B6/sk not_active IP Right Cessation
- 1997-04-01 AU AU21755/97A patent/AU732793B2/en not_active Expired
- 1997-04-01 SK SK50016-2007A patent/SK287889B6/sk not_active IP Right Cessation
- 1997-04-01 EP EP97914534A patent/EP0894130B1/de not_active Expired - Lifetime
- 1997-04-01 WO PCT/IL1997/000117 patent/WO1997037016A1/en not_active Ceased
- 1997-04-01 CN CNB971951934A patent/CN1197966C/zh not_active Expired - Lifetime
- 1997-04-01 EA EA199800885A patent/EA004309B1/ru not_active IP Right Cessation
- 1997-04-01 DE DE69738370T patent/DE69738370T2/de not_active Expired - Lifetime
- 1997-04-01 ES ES97914534T patent/ES2294796T3/es not_active Expired - Lifetime
- 1997-04-01 CZ CZ0318398A patent/CZ299682B6/cs not_active IP Right Cessation
- 1997-04-01 CZ CZ20060018A patent/CZ299094B6/cs not_active IP Right Cessation
- 1997-04-01 CZ CZ20060017A patent/CZ298866B6/cs not_active IP Right Cessation
- 1997-04-01 HU HU9902429A patent/HU226328B1/hu unknown
- 1997-04-01 AT AT97914534T patent/ATE380866T1/de active
- 1997-04-01 SK SK1361-98A patent/SK287085B6/sk not_active IP Right Cessation
-
1998
- 1998-09-29 NO NO19984551A patent/NO327054B1/no not_active IP Right Cessation
- 1998-10-07 BG BG102817A patent/BG64755B1/bg unknown
-
2009
- 2009-02-03 US US12/365,136 patent/US8236507B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69738370D1 (de) | Modulatoren des tnf-rezeptor-assoziierten faktors, deren herstellung und verwendungen | |
| IL193886A (en) | Antibodies that bind to ldcam sequences | |
| ATE113295T1 (de) | Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren. | |
| PT917571E (pt) | Gene relacionado com agouti | |
| TW327194B (en) | Novel amyloid precursor proteins and methods of using same | |
| WO1998041629A3 (en) | Death domain containing receptor 5 | |
| DK0961831T3 (da) | Humant alfa-endokin | |
| ATE184052T1 (de) | Gdf-1 und uog1 proteine | |
| PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
| DK1015587T3 (da) | DcR3 polypeptid, en TNFR-homolog | |
| CY1105161T1 (el) | Ομολογα προσδεματος τιε | |
| ATE424410T1 (de) | Interleukin-19. | |
| EP0232523A3 (en) | Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins | |
| FI863626A7 (fi) | DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä. | |
| DK0629238T3 (da) | Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi | |
| WO2000024771A3 (en) | Nucleic acids encoding osteoprotegerin-like proteins and methods of using same | |
| WO2000032778A3 (en) | Methods and compositions for inhibiting neoplastic cell growth | |
| ATE408687T1 (de) | Semaphorin polypeptide | |
| AR008064A1 (es) | Una proteina ligante del factor de necrosis tumoral truncada de bajo peso molecular (tnf bp), un polinucleotido codificante de dicha proteina, un vector, una celula hospedante, metodos para producir dicha proteina, una composicion farmaceutica, metodo para tratar una enfermedad mediada por tnf bp y usos de dicha proteina. | |
| AU4405689A (en) | New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines | |
| EP1865061A3 (de) | IL-17-homologe Polypeptide und ihre therapeutische Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0894130 Country of ref document: EP |